189 related articles for article (PubMed ID: 21257915)
1. Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide.
Nagasaka Y; Buys ES; Spagnolli E; Steinbicker AU; Hayton SR; Rauwerdink KM; Brouckaert P; Zapol WM; Bloch KD
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1477-83. PubMed ID: 21257915
[TBL] [Abstract][Full Text] [Related]
2. sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling.
Cawley SM; Kolodziej S; Ichinose F; Brouckaert P; Buys ES; Bloch KD
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H157-63. PubMed ID: 21536853
[TBL] [Abstract][Full Text] [Related]
3. Involvement of soluble guanylate cyclase alpha(1) and alpha(2), and SK(Ca) channels in NANC relaxation of mouse distal colon.
Dhaese I; Vanneste G; Sips P; Buys E; Brouckaert P; Lefebvre RA
Eur J Pharmacol; 2008 Jul; 589(1-3):251-9. PubMed ID: 18572161
[TBL] [Abstract][Full Text] [Related]
4. Soluble guanylate cyclase alpha1beta1 limits stroke size and attenuates neurological injury.
Atochin DN; Yuzawa I; Li Q; Rauwerdink KM; Malhotra R; Chang J; Brouckaert P; Ayata C; Moskowitz MA; Bloch KD; Huang PL; Buys ES
Stroke; 2010 Aug; 41(8):1815-9. PubMed ID: 20595671
[TBL] [Abstract][Full Text] [Related]
5. Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.
Vanneste G; Dhaese I; Sips P; Buys E; Brouckaert P; Lefebvre RA
J Physiol; 2007 Nov; 584(Pt 3):907-20. PubMed ID: 17717014
[TBL] [Abstract][Full Text] [Related]
6. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms.
Wang E; Feng Y; Zhang M; Zou L; Li Y; Buys ES; Huang P; Brouckaert P; Chao W
Anesthesiology; 2011 Mar; 114(3):603-13. PubMed ID: 21270629
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
Korkmaz S; Radovits T; Barnucz E; Hirschberg K; Neugebauer P; Loganathan S; Veres G; Páli S; Seidel B; Zöllner S; Karck M; Szabó G
Circulation; 2009 Aug; 120(8):677-86. PubMed ID: 19667237
[TBL] [Abstract][Full Text] [Related]
9. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
10. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
Salloum FN; Das A; Samidurai A; Hoke NN; Chau VQ; Ockaili RA; Stasch JP; Kukreja RC
Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1347-54. PubMed ID: 22268103
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo studies on the importance of the soluble guanylyl cyclase α1 subunit in penile erection.
Decaluwé K; Nimmegeers S; Thoonen R; Buys E; Brouckaert P; Van de Voorde J
World J Urol; 2010 Oct; 28(5):643-50. PubMed ID: 20098992
[TBL] [Abstract][Full Text] [Related]
12. Inhalation of NO during myocardial ischemia reduces infarct size and improves cardiac function.
Neye N; Enigk F; Shiva S; Habazettl H; Plesnila N; Kuppe H; Gladwin MT; Kuebler WM
Intensive Care Med; 2012 Aug; 38(8):1381-91. PubMed ID: 22653370
[TBL] [Abstract][Full Text] [Related]
13. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
[TBL] [Abstract][Full Text] [Related]
14. The alpha1 isoform of soluble guanylate cyclase regulates cardiac contractility but is not required for ischemic preconditioning.
Sips PY; Brouckaert P; Ichinose F
Basic Res Cardiol; 2011 Jun; 106(4):635-43. PubMed ID: 21394564
[TBL] [Abstract][Full Text] [Related]
15. Soluble guanylate cyclase modulates alveolarization in the newborn lung.
Bachiller PR; Cornog KH; Kato R; Buys ES; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2013 Oct; 305(8):L569-81. PubMed ID: 23934926
[TBL] [Abstract][Full Text] [Related]
16. Role of the soluble guanylyl cyclase alpha1-subunit in mice corpus cavernosum smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Decaluwé K; Brouckaert P; Van de Voorde J
Int J Impot Res; 2008; 20(3):278-84. PubMed ID: 18059500
[TBL] [Abstract][Full Text] [Related]
17. Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
Erdmann J; Stark K; Esslinger UB; Rumpf PM; Koesling D; de Wit C; Kaiser FJ; Braunholz D; Medack A; Fischer M; Zimmermann ME; Tennstedt S; Graf E; Eck S; Aherrahrou Z; Nahrstaedt J; Willenborg C; Bruse P; Brænne I; Nöthen MM; Hofmann P; Braund PS; Mergia E; Reinhard W; Burgdorf C; Schreiber S; Balmforth AJ; Hall AS; Bertram L; Steinhagen-Thiessen E; Li SC; März W; Reilly M; Kathiresan S; McPherson R; Walter U; ; Ott J; Samani NJ; Strom TM; Meitinger T; Hengstenberg C; Schunkert H
Nature; 2013 Dec; 504(7480):432-6. PubMed ID: 24213632
[TBL] [Abstract][Full Text] [Related]
18. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
[TBL] [Abstract][Full Text] [Related]
19. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
[TBL] [Abstract][Full Text] [Related]
20. sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.
Buys ES; Cauwels A; Raher MJ; Passeri JJ; Hobai I; Cawley SM; Rauwerdink KM; Thibault H; Sips PY; Thoonen R; Scherrer-Crosbie M; Ichinose F; Brouckaert P; Bloch KD
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H654-63. PubMed ID: 19502556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
